Literature DB >> 19016271

Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.

P Sun1, J-B Xiang, Z-Y Chen.   

Abstract

BACKGROUND: There is no consensus of opinion about postoperative adjuvant chemotherapy after radical surgery for advanced gastric cancer. This is a meta-analysis of the published results of relevant randomized clinical trials (RCTs).
METHODS: Electronic databases from January 1998 to December 2007 were searched and 12 RCTs were selected. These included a total of 3809 patients. The hazard ratio (HR) for overall survival was calculated.
RESULTS: The pooled HR for overall survival was 0.78 (95 per cent confidence interval 0.71 to 0.85) in favour of chemotherapy. Subgroup analysis showed that the advantage of chemotherapy was not influenced by depth of tumour infiltration, status of lymph node metastasis, type of lymphadenectomy, geographical distribution of patients or route of drug administration.
CONCLUSIONS: Postoperative chemotherapy can improve overall survival after radical surgery for gastric cancer; there is no standardized chemotherapy regimen. Japanese-style D2 radical surgery plus oral 5-fluorouracil appears an effective treatment at present. Copyright (c) 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2009        PMID: 19016271     DOI: 10.1002/bjs.6408

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  35 in total

1.  Treatment of resectable gastric cancer.

Authors:  Johan L Dikken; Cornelis J H van de Velde; Daniel G Coit; Manish A Shah; Marcel Verheij; Annemieke Cats
Journal:  Therap Adv Gastroenterol       Date:  2012-01       Impact factor: 4.409

2.  Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China.

Authors:  Miao-zhen Qiu; Zhi-qiang Wang; Dong-sheng Zhang; Hui-yan Luo; Zhi-wei Zhou; Feng-hua Wang; Yu-hong Li; Wen-qi Jiang; Rui-hua Xu
Journal:  Tumour Biol       Date:  2010-12-23

3.  Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Authors:  Leyla Kilic; Cetin Ordu; Meltem Ekenel; Ibrahim Yildiz; Serkan Keskin; Fatma Sen; Zeynep Gural; Oktar Asoglu; Ahmet Kizir; Faruk Aykan
Journal:  Med Oncol       Date:  2013-07-23       Impact factor: 3.064

4.  Neo-adjuvant chemotherapy followed by surgery and chemotherapy or by surgery and chemoradiotherapy for patients with resectable gastric cancer (CRITICS).

Authors:  Johan L Dikken; Johanna W van Sandick; H A Maurits Swellengrebel; Pehr A Lind; Hein Putter; Edwin P M Jansen; Henk Boot; Nicole C T van Grieken; Cornelis J H van de Velde; Marcel Verheij; Annemieke Cats
Journal:  BMC Cancer       Date:  2011-08-02       Impact factor: 4.430

5.  Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer.

Authors:  Sheng-Liu Xue; Hua-Fang Su; Xiao-Qu Hu; Xia Deng; Mei-Long Hu; Cong-Ying Xie
Journal:  Oncol Lett       Date:  2012-09-13       Impact factor: 2.967

6.  Chemotherapy for operable gastric cancer: current perspectives.

Authors:  Vikram K Jain; David Cunningham; Sheela Rao
Journal:  Indian J Surg Oncol       Date:  2012-03-01

7.  Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.

Authors:  Bolag Altan; Takehiko Yokobori; Munenori Ide; Erito Mochiki; Yoshitaka Toyomasu; Norimichi Kogure; Akiharu Kimura; Keigo Hara; Tuya Bai; Pinjie Bao; Masaki Suzuki; Kyoichi Ogata; Takayuki Asao; Masahiko Nishiyama; Tetsunari Oyama; Hiroyuki Kuwano
Journal:  Gastric Cancer       Date:  2015-10-15       Impact factor: 7.370

8.  Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial.

Authors:  M A Gordon; H M Gundacker; J Benedetti; J S Macdonald; J C Baranda; W J Levin; C D Blanke; W Elatre; P Weng; J Y Zhou; H J Lenz; M F Press
Journal:  Ann Oncol       Date:  2013-03-22       Impact factor: 32.976

9.  Development of RNA binding proteins expression signature for prognosis prediction in gastric cancer patients.

Authors:  Liqiang Zhou; You Wu; Lin Xin; Qi Zhou; Shihao Li; Yiwu Yuan; Jinliang Wang; Dengzhong Wu
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

Review 10.  Extent of lymphadenectomy and perioperative therapies: two open issues in gastric cancer.

Authors:  Andrea Giuliani; Michelangelo Miccini; Luigi Basso
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.